Table 1. A meta-analysis of miR expression profile in human DPN.
Author | Year | Country | Number | Age (mean ± standard deviation, year) | Gender (male/female) | miR | |||
DM | NC | DM | NC | DM | NC | ||||
Zhao H 26 | 2010 | China | 40 | 15 | 69 ± 13 | 54 ± 14 | 17/23 | 6/9 | miR-375 |
Jiang LQ 27 | 2013 | Sweden | 24 | 29 | 60.1 ± 5.0 | 60.9 ± 4.7 | 18/6 | 19/10 | miR-98, let-7b, let-7c, let-7f, let-7g, and let-7i |
Pescador N 9 | 2013 | China | 99 | 100 | 69.4 ± 7.12 | 42.9 ± 12.13 | 53/46 | 50/50 | miR-138, miR-376a, miR-15b, and miR-503 |
Zhang T 28 | 2013 | China | 30 | 30 | 63 ± 8.56 | 61 ± 9 | 16/14 | 16/14 | miR-126 |
Liu Y 29 | 2014 | China | 160 | 138 | 50.2 ± 6.7 | 46.7 ± 7.2 | 78/82 | 67/71 | miR-126 |
Ortega FJ 30 | 2014 | Spain | 30 | 35 | 54 ± 10 | 48.1 ± 10.1 | 30/0 | 35/0 | miR-140-5p, miR-142-3p, miR-222, miR-423-5p, miR-125b, miR-192, miR-195, miR-130b, miR-532-5p, and miR-126 |
Sun K 31 | 2014 | China | 100 | 100 | 51.33 ± 11.75 | 48.55 ± 12.41 | 54/46 | 44/56 | miR-375 |
Yang Z 32 | 2014 | China | 24 | 20 | 51.13 ± 9.214 | 46.65 ± 16.181 | 16/8 | 8/12 | miR-23a |
Al-Kafaji G 33 | 2015 | Arabian | 24 | 24 | 52 ± 6 | 49 ± 9.1 | 10/14 | 13/11 | miR-15a |
Olivieri F 34 | 2015 | Italy | 117 | 76 | 66.51 ± 7.48 | 64.25 ± 7.56 | 69/48 | 36/40 | MiR-21-5p and miR-126a-3p |
Wu L 35 | 2015 | China | 25 | 20 | 46.7 ± 8.6 | 45.5 ± 10.2 | - | - | miR-152, miR-17, miR-138, and miR-593 |
Dai X 36 | 2015 | China | 85 | 80 | 57.4 ± 9.6 | 59.5 ± 13.5 | 44/41 | 43/37 | miR-483-5p, miR-19a, miR-29a, miR-20a, miR-24, and miR-25 |
Wang C 37 | 2016 | China | 92 | 92 | 47.7 ± 13.9 | 50.2 ± 14.2 | 58/34 | 56/36 | miR-661, miR-571, miR-770-5p, miR-892b, and miR-1303 |
Wu K 38 | 2016 | China | 14 | 21 | 44 ± 6 | 42 ± 5 | - | - | miR-126 |
Yan S 39 | 2016 | China | 50 | 50 | 46.22 ± 6.897 | 45.52 ± 6.215 | 27/23 | 22/28 | miR-1249, miR-572, miR-1249, and miR-572 |
Yang S 40 | 2016 | China | 58 | 30 | 49.8 ± 9.1 | 48.2 ± 8.9 | - | - | miR-144 and miR-223 |
Note: DPN, diabetic peripheral neuropathy; DM, diabetes mellitus; NC, normal control; miR, microRNA.